Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
CGD NOTES
May 31, 2024
CGD NOTES
June 05, 2024
CGD NOTES
May 23, 2024
WORKING PAPERS
June 05, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
BRIEFS
July 31, 2023
India is racing against the clock in its fight against antimicrobial resistance. A combination of complex regulatory and procurement systems, a lack of health insurance penetration, and little groundwork on state and national action plans has stymied progress. A multifold approach is needed to impro...
BRIEFS
June 08, 2023
Facing the high—and rising—burden of antimicrobial resistance (AMR), Brazil has an opportunity to improve access, stewardship, and innovation for critical antimicrobials at the national, regional, and/or global level(s) by modifying procurement arrangements. Brazil is positioned for significant dome...
BRIEFS
July 19, 2022
This brief summarizes the final report of the working group. The report collates resources and insights on progress in implementing and using impact evaluations for decision making and proposes five ways to improve impact evaluation funding and practice, directed to the development community
BRIEFS
July 19, 2022
This brief lays out how the World Bank can more systematically embed impact evaluation and related data and evidence functions into programming, implementation, and country support. The recommendations are based on working group discussions, consultations with experts currently and formerly at the W...
BRIEFS
July 19, 2022
This brief details how philanthropies can invest in a new era of evidence-informed policy decisions to improve and save lives. It is based on working group discussions, a roundtable and numerous consultations with philanthropic funders and other experts, and background research over the course of th...
BRIEFS
April 28, 2022
COVID-19 has disrupted health systems across the globe. Nigeria reported its first COVID-19 case in February 2020, and, since then, the government has rolled out four vaccines to help control the pandemic—Moderna, Oxford-Astra Zeneca (AZ), Johnson & Johnson (J&J) and Pfizer-BioNTech.